Designate Your Fundraising
Every Obliterider can direct their support to the area of our work that is most meaningful to them, including a specific disease area, program, faculty member, or clinician. Every dollar your community donates to your Obliteride fundraising effort (100%!) will support that work.
About Fred Hutch
Fred Hutchinson Cancer Center unites individualized care and advanced research to provide the latest cancer treatment options while accelerating discoveries that prevent, treat and cure cancer and infectious diseases worldwide.
Based in Seattle, Fred Hutch is an independent, nonprofit organization and the only National Cancer Institute-designated cancer center in Washington. We have earned a global reputation for our track record of discoveries in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services and has network affiliations with hospitals in four states. Fred Hutch also serves as UW Medicine’s cancer program.
Fred Hutchinson Cancer Center is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. Our relationship allows for enhanced care coordination between a top-ranked cancer center and a leading integrated health system and accelerates the latest scientific breakthroughs in cancer and other life-threatening diseases.
Fred Hutch is proud to raise funds that fuel the adult oncology program on behalf of both Fred Hutch and UW Medicine.
Learning how cells fix their broken DNA to understand cancer origins and inform new therapies.
Understanding our immune response to new and evolving viruses to improve treatments for current and emerging threats.
Developing therapies that optimize the cancer-fighting power of immune T cells while reducing side effects.
Studying how a type of bacteria leads to aggressive colorectal cancer to better prevent and treat it.
Improving screening by identifying genetic and other risk factors for prostate cancer in diverse populations.
Learning how immune T cells behave during and after treatment to improve immune-based therapies for children.
Refining blood stem cell transplantation and testing it to treat severe autoimmune diseases.
Researching mosquito- and tick-borne flaviviruses, including dengue and Zika, that threaten people worldwide.
Linking cellular changes to different prostate tumor pathologies to enhance diagnosis.
Illuminating the role of glia, which form one-half of our brain cells, in Alzheimer’s and autism.
Distilling complex genetic and environmental factors to better predict disease risk.
Uncovering how blood stem cells repopulate the bone marrow after radiation and transplant.
Improving stem cell transplantation and follow-up to catch relapse early.
Designing new immunotherapies that harness immune T cells to fight lung and skin cancers.